14-day Premium Trial Subscription Try For FreeTry Free
$0.90
-0.0035 (-0.387%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.86 $1.27 Friday, 3rd May 2024 BLUE stock ended at $0.90. This is 0.387% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 6.11% from a day low at $0.89 to a day high of $0.94.
90 days $0.86 $1.92
52 weeks $0.86 $5.53

Historical bluebird bio prices

Date Open High Low Close Volume
Jan 18, 2022 $8.50 $8.59 $7.85 $7.91 2 143 100
Jan 14, 2022 $8.57 $8.76 $8.18 $8.73 2 181 200
Jan 13, 2022 $8.87 $9.08 $8.50 $8.52 1 753 900
Jan 12, 2022 $9.54 $9.57 $8.90 $8.92 1 318 200
Jan 11, 2022 $9.47 $9.85 $9.46 $9.57 1 215 700
Jan 10, 2022 $9.36 $9.43 $8.96 $9.41 1 835 100
Jan 07, 2022 $9.77 $10.07 $9.53 $9.55 918 900
Jan 06, 2022 $9.94 $10.15 $9.69 $9.80 1 390 300
Jan 05, 2022 $10.24 $10.51 $9.90 $9.91 1 285 421
Jan 04, 2022 $10.58 $10.74 $10.12 $10.28 986 808
Jan 03, 2022 $10.09 $10.68 $10.09 $10.60 1 234 823
Dec 31, 2021 $10.43 $10.64 $9.91 $9.99 1 345 815
Dec 30, 2021 $10.42 $10.84 $10.31 $10.35 1 533 650
Dec 29, 2021 $10.74 $10.82 $10.26 $10.41 857 922
Dec 28, 2021 $10.93 $11.58 $10.77 $10.77 2 489 631
Dec 27, 2021 $11.38 $11.43 $10.77 $10.94 4 161 581
Dec 23, 2021 $11.21 $11.70 $11.07 $11.40 1 852 042
Dec 22, 2021 $11.49 $11.55 $11.04 $11.12 2 709 667
Dec 21, 2021 $10.50 $11.59 $10.37 $11.58 2 890 124
Dec 20, 2021 $8.45 $10.76 $8.12 $10.71 9 153 305
Dec 17, 2021 $9.14 $10.69 $9.11 $10.62 8 873 007
Dec 16, 2021 $9.56 $9.87 $9.30 $9.37 1 338 206
Dec 15, 2021 $9.22 $9.51 $8.83 $9.51 2 239 000
Dec 14, 2021 $9.40 $9.74 $9.14 $9.16 2 221 988
Dec 13, 2021 $9.48 $9.69 $8.98 $9.51 4 405 942
Click to get the best stock tips daily for free!

About bluebird bio

bluebird bio bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy. The company's clini... BLUE Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT